What'sNearbyTM

What are you looking for?

Close Search
      We apologize for the inconvenience

      The people search feature on Superpages.com is temporarily unavailable. You can still search for people on yellowpages.com since Yellow Pages and Superpages are part of one company.

      You will be automatically re-directed to People Search on yellowpages.com in .

      Mohammadbagher Ziari, MD

      Add to Favorites
      Be the first to review!
      Physicians & Surgeons, Oncology, Physicians & Surgeons, Physicians & Surgeons, Internal Medicine

      1640 Newport Blvd Ste 400, Costa Mesa, CA 92627

      949-999-2400

      CLOSED NOW: 
      Today: 8:00 am - 5:00 pm
      CallWebsite

      REVIEWS write reviewWrite a Review

      Be the first to review!
      First-classBetter than mostAbout what I expectedNot the worst...Disappointing
      DETAILS
      General Info
      Dr. Mo Ziari is a board-certified UCI Health hematologist and medical oncologist who specializes in the diagnosis, treatment and management of solid tumors as well as benign and malignant hematological conditions. He earned his medical degree at Shiraz University of Medical Sciences in Shiraz, Iran. Next, he completed a residency in internal medicine at Saint Louis University School of Medicine in Saint Louis, Mo., followed by fellowship training in hematology and oncology at the University of Texas Southwestern in Dallas. Ziari delivers leading-edge cancer therapies, including chemotherapy, endocrine therapy, targeted therapy, monoclonal antibodies and immunotherapy. He is the author of numerous peer-reviewed journal articles. He sees patients in Costa Mesa and Orange.
      Hours
      Regular Hours
      Mon - Fri:
      Sat - SunClosed
      Categories
      Physicians & Surgeons, Oncology, Physicians & Surgeons, Physicians & Surgeons, Internal Medicine
      Other Link

      http://www.ucihealth.org/find-a-doctor/z/mohammadbagher-ziari

      Provided by
      Data provided by one or more of the following: Thryv, Data Axle, Yext.